RWA Wealth Partners LLC Buys 565 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

RWA Wealth Partners LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 60,031 shares of the healthcare conglomerate’s stock after buying an additional 565 shares during the period. RWA Wealth Partners LLC’s holdings in UnitedHealth Group were worth $30,368,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Wallace Capital Management Inc. increased its position in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after acquiring an additional 19 shares during the period. Western Pacific Wealth Management LP raised its position in shares of UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after buying an additional 19 shares during the last quarter. MCF Advisors LLC grew its position in UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after buying an additional 20 shares in the last quarter. Axiom Financial Strategies LLC raised its holdings in UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after acquiring an additional 20 shares in the last quarter. Finally, Richwood Investment Advisors LLC grew its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after purchasing an additional 20 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on UNH shares. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.0 %

Shares of NYSE UNH opened at $515.47 on Friday. The firm has a 50 day moving average price of $508.81 and a 200 day moving average price of $544.24. The stock has a market cap of $471.51 billion, a P/E ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.